Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

November 1, 2011; Volume 52,Issue 11

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 11A-12A;

SNM Newsline

  • You have access
    Oncology
    Steven M. Larson
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 13N-20N;
  • You have access
    General Nuclear Medicine
    Harvey A. Ziessman
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 20N-28N;
  • You have access
    Gathering Member Feedback on SNM Name Change
    Carolyn J. Anderson
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 29N-30N;
  • You have access
    Notification of Proposed SNM Bylaws Change
    James M. Woolfenden
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 30N-31N;
  • You have access
    Molecular Imaging Summit at SNM Mid-Winter Meeting
    Jonathan McConathy
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 32N;
  • You have access
    An Education Opportunity for All: SNM's Mid-Winter Meeting
    George Segall
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 33N;

Focus on Molecular Imaging

  • You have access
    CXCR4-Based Imaging Agents
    Lauren E. Woodard and Sridhar Nimmagadda
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1665-1669; DOI: https://doi.org/10.2967/jnumed.111.097733

Invited Perspective

  • You have access
    Looking Through the Vascular Normalization Window: Timing Antiangiogenic Treatment and Chemotherapy with 99mTc-Annexin A5
    Michael R. Lewis
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1670-1672; DOI: https://doi.org/10.2967/jnumed.111.097725

Clinical Investigations

  • You have access
    Cost-Effectiveness of Routine 18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia
    Fidel J. Vos, Chantal P. Bleeker-Rovers, Bart Jan Kullberg, Eddy M.M. Adang and Wim J.G. Oyen
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1673-1678; DOI: https://doi.org/10.2967/jnumed.111.089714
  • You have access
    Treatment with Octreotide Does Not Reduce Tumor Uptake of 68Ga-DOTATATE as Measured by PET/CT in Patients with Neuroendocrine Tumors
    Alexander R. Haug, Axel Rominger, Mona Mustafa, Christoph Auernhammer, Burkhard Göke, Gerwin P. Schmidt, Björn Wängler, Paul Cumming, Peter Bartenstein and Marcus Hacker
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1679-1683; DOI: https://doi.org/10.2967/jnumed.111.089276
  • You have access
    18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
    Matthias R. Benz, Ken Herrmann, Franziska Walter, Edward B. Garon, Karen L. Reckamp, Robert Figlin, Michael E. Phelps, Wolfgang A. Weber, Johannes Czernin and Martin S. Allen-Auerbach
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1684-1689; DOI: https://doi.org/10.2967/jnumed.111.095257
  • You have access
    Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non–Small Cell Lung Cancer Tumor Delineation
    Mathieu Hatt, Catherine Cheze-le Rest, Angela van Baardwijk, Philippe Lambin, Olivier Pradier and Dimitris Visvikis
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1690-1697; DOI: https://doi.org/10.2967/jnumed.111.092767
  • You have access
    Investigating Vulnerable Atheroma Using Combined 18F-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation
    Leon J. Menezes, Carl W. Kotze, Obi Agu, Toby Richards, Jocelyn Brookes, Vicky J. Goh, Manuel Rodriguez-Justo, Raymondo Endozo, Richard Harvey, Syed W. Yusuf, Peter J. Ell and Ashley M. Groves
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1698-1703; DOI: https://doi.org/10.2967/jnumed.111.093724
  • You have access
    Structural Abnormalities of the Coronary Arterial Wall—in Addition to Luminal Narrowing—Affect Myocardial Blood Flow Reserve
    Riccardo Liga, Cecilia Marini, Michele Coceani, Elena Filidei, Mathis Schlueter, Massimiliano Bianchi, Giuseppe Rossi, Silvia Pardini, Piero Salvadori, Oberdan Parodi, Daniele Rovai, Gianmario Sambuceti, Paolo Marraccini and Danilo Neglia
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1704-1712; DOI: https://doi.org/10.2967/jnumed.111.091009
  • You have access
    18F-FDG Uptake Rate Is a Biomarker of Eosinophilic Inflammation and Airway Response in Asthma
    R. Scott Harris, José G. Venegas, Chanikarn Wongviriyawong, Tilo Winkler, Mamary Kone, Guido Musch, Marcos F. Vidal Melo, Nicolas de Prost, Daniel L. Hamilos, Roshi Afshar, Josalyn Cho, Andrew D. Luster and Benjamin D. Medoff
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1713-1720; DOI: https://doi.org/10.2967/jnumed.110.086355
  • You have access
    Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis
    Hans-Jürgen Biersack, Holger Palmedo, Andrej Andris, Stefan Rogenhofer, Furn F. Knapp, Stefan Guhlke, Samer Ezziddin, Jan Bucerius and Dirk von Mallek
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1721-1726; DOI: https://doi.org/10.2967/jnumed.111.093674

Brief Communication

  • You have access
    Practical Approach for Comparative Analysis of Multilesion Molecular Imaging Using a Semiautomated Program for PET/CT
    Josef J. Fox, Estelle Autran-Blanc, Michael J. Morris, Somali Gavane, Sadek Nehmeh, André Van Nuffel, Mithat Gönen, Heiko Schöder, John L. Humm, Howard I. Scher and Steven M. Larson
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1727-1732; DOI: https://doi.org/10.2967/jnumed.111.089326

Continuing Education

  • You have access
    Brain Amyloid Imaging
    Christopher C. Rowe and Victor L. Villemagne
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1733-1740; DOI: https://doi.org/10.2967/jnumed.110.076315

Basic Science Investigations

  • You have access
    National Electrical Manufacturers Association NU-4 Performance Evaluation of the PET Component of the NanoPET/CT Preclinical PET/CT Scanner
    Istvan Szanda, Jane Mackewn, Gergely Patay, Peter Major, Kavitha Sunassee, Gregory E. Mullen, Gabor Nemeth, York Haemisch, Philip J. Blower and Paul K. Marsden
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1741-1747; DOI: https://doi.org/10.2967/jnumed.111.088260
  • You have access
    The Precision and Sensitivity of 18F-Fluoride PET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods
    Musib Siddique, Michelle L. Frost, Glen M. Blake, Amelia E.B. Moore, Yosra Al-Beyatti, Paul K. Marsden, Paul J. Schleyer and Ignac Fogelman
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1748-1755; DOI: https://doi.org/10.2967/jnumed.111.093195
  • You have access
    Combined RNA Interference of Hexokinase II and 131I-Sodium Iodide Symporter Gene Therapy for Anaplastic Thyroid Carcinoma
    Jung Eun Kim, Byeong-Cheol Ahn, Mi-Hye Hwang, Yong Hyun Jeon, Shin Young Jeong, Sang-Woo Lee and Jaetae Lee
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1756-1763; DOI: https://doi.org/10.2967/jnumed.111.090266
  • You have access
    Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model
    Robbie Robertson, Melissa Saylor Germanos, Mark G. Manfredi, Peter G. Smith and Matthew D. Silva
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1764-1769; DOI: https://doi.org/10.2967/jnumed.111.091710
  • You have access
    Evaluation of the Role of Tumor-Associated Macrophages in an Experimental Model of Peritoneal Carcinomatosis Using 18F-FDG PET
    Lucia Cottone, Silvia Valtorta, Annalisa Capobianco, Sara Belloli, Patrizia Rovere-Querini, Ferruccio Fazio, Angelo A. Manfredi and Rosa Maria Moresco
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1770-1777; DOI: https://doi.org/10.2967/jnumed.111.089177
  • You have access
    Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
    Anton G.T. Terwisscha van Scheltinga, Gooitzen M. van Dam, Wouter B. Nagengast, Vasilis Ntziachristos, Harry Hollema, Jennifer L. Herek, Carolien P. Schröder, Jos G.W. Kosterink, Marjolijn N. Lub-de Hoog and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1778-1785; DOI: https://doi.org/10.2967/jnumed.111.092833
  • You have access
    99mTc-(CO)3 His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab
    Christel Vangestel, Christophe Van de Wiele, Nancy Van Damme, Steven Staelens, Patrick Pauwels, Chris P.M. Reutelingsperger and Marc Peeters
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1786-1794; DOI: https://doi.org/10.2967/jnumed.111.092650
  • You have access
    Atherosclerosis Plaque Heterogeneity and Response to Therapy Detected by In Vivo Molecular Imaging of Matrix Metalloproteinase Activation
    Mahmoud Razavian, Sina Tavakoli, Jiasheng Zhang, Lei Nie, Lawrence W. Dobrucki, Albert J. Sinusas, Michael Azure, Simon Robinson and Mehran M. Sadeghi
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1795-1802; DOI: https://doi.org/10.2967/jnumed.111.092379
  • You have access
    PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent
    Eleni Gourni, Oliver Demmer, Margret Schottelius, Calogero D'Alessandria, Stefan Schulz, Ingrid Dijkgraaf, Udo Schumacher, Markus Schwaiger, Horst Kessler and Hans-Jürgen Wester
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1803-1810; DOI: https://doi.org/10.2967/jnumed.111.098798
  • You have access
    Comparison of 4 Radiolabeled Antagonists for Serotonin 5-HT7 Receptor Neuroimaging: Toward the First PET Radiotracer
    Laetitia Lemoine, Julien Andries, Didier Le Bars, Thierry Billard and Luc Zimmer
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1811-1818; DOI: https://doi.org/10.2967/jnumed.111.089185
  • You have access
    64Cu-Labeled Peptide for PET of Breast Carcinomas Expressing the Thomsen-Friedenreich Carbohydrate Antigen
    Senthil R. Kumar, Fabio A. Gallazzi, Thomas P. Quinn and Susan L. Deutscher
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1819-1826; DOI: https://doi.org/10.2967/jnumed.111.093716
  • You have access
    Micro-CT for Anatomic Referencing in PET and SPECT: Radiation Dose, Biologic Damage, and Image Quality
    Veerle Kersemans, James Thompson, Bart Cornelissen, Michael Woodcock, Philip D. Allen, Nico Buls, Ruth J Muschel, Mark A. Hill and Sean C. Smart
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1827-1833; DOI: https://doi.org/10.2967/jnumed.111.089151

Erratum

  • You have access
    Erratum
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1818;

Book Review

  • You have access
    Final FRCR 2B Long Cases: A Survival Guide
    Aurelio Matamoros
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1834; DOI: https://doi.org/10.2967/jnumed.111.095984

Letters to the Editor

  • You have access
    Simplified Quantification of Myocardial Flow Reserve with 18F-Flurpiridaz: Validation with Microspheres in a Pig Model
    Nils P. Johnson and K. Lance Gould
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1835; DOI: https://doi.org/10.2967/jnumed.111.091850
  • You have access
    Reply: Simplified Quantification of Myocardial Flow Reserve with 18F-Flurpiridaz: Validation with Microspheres in a Pig Model
    Hossam M. Sherif, Stephan G. Nekolla and Markus Schwaiger
    Journal of Nuclear Medicine November 1, 2011, 52 (11) 1835-1836; DOI: https://doi.org/10.2967/jnumed.111.092056
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 52 (11)
Journal of Nuclear Medicine
Vol. 52, Issue 11
November 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis
  • Brain Amyloid Imaging
  • PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent
Sign up for alerts

Jump to

  • This Month in JNM
  • SNM Newsline
  • Focus on Molecular Imaging
  • Invited Perspective
  • Clinical Investigations
  • Brief Communication
  • Continuing Education
  • Basic Science Investigations
  • Erratum
  • Book Review
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire